MD, PHD
FULL PROFESSOR AND DIVISION HEAD OF DIGESTIVE ONCOLOGY AT UNIVERSITY OF LEUVEN AND UNIVERSITY HOSPITALS GASTHUISBERG, LEUVEN, BELGIUM

About Our Speaker
Real-world evidence highlights the importance of 3L- and 4L-treatment selection to improve mCRC patients outcomes.